Clinical Trial Update: Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating antiviral and antifibrotic liver therapy for hepatitis C in drinkers and non-drinkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED